← All stocks

PUMA BIOTECHNOLOGY, INC.

PBYI Net selling
CIK 0001401667 #3143 in the set updated 17 Sep 2026
Bought (120 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$175.11M
$3.94M on a plan · $4.30M straight out of an exercise
Sold at will
$166.87M
224 of 292 sales
Net
−$175.11M
−$166.87M against sales at will

By person

20 insiders · 292 transactions
71.1×

Alan H. Auerbach holds 71.1 times base salary in stock. $66.25M of shares against $931.33K in salary for 2025.

Salary from the company's own proxy. The shares are what Alan H. Auerbach last reported holding, valued at $9.12, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
ADAGE CAPITAL PARTNERS GP, L.L.C. entity
10% owner
$157.55M (30)
−$157.55M
3,696,580
7.16%
$33.72M
−35.0%
AUERBACH ALAN H
President and CEO
$5.90M (70)
−$5.90M
7,261,671
14.07%
$66.25M
+79.7%
BRYCE RICHARD PAUL
SEE REMARKS
$4.49M (40) scheduled
−$4.49M
121,662
0.2357%
$1.11M
+574.8%
Senderowicz Adrian
Director
$1.10M (7)
−$1.10M
27,000
0.0523%
$246.32K
WILSON TROY EDWARD
Director
$959.24K (8)
−$959.24K
55,300
0.1071%
$504.50K
+6,044%
MOYES JAY M
Director
$919.63K (8)
−$919.63K
58,322
0.1130%
$532.07K
Cesano Alessandra
Director
$699.21K (3) scheduled
−$699.21K
56,700
0.1098%
$517.27K
Lo Steven
Chief Commercial Officer
$604.10K (6)
−$604.10K
19,557
0.0379%
$178.42K
HUNT DOUGLAS M
See Remarks
$485.11K (39) scheduled
−$485.11K
196,841
0.3813%
$1.80M
+4,274%
NOUGUES MAXIMO F
Chief Financial Officer
$483.39K (35) scheduled
−$483.39K
230,637
0.4468%
$2.10M
EYLER CHARLES R
SEE REMARKS
$460.97K (10)
−$460.97K
31,957
0.0619%
$291.54K
MILLER MICHAEL PATRICK
Director
$456.71K (6)
−$456.71K
81,000
0.1569%
$738.96K
Ludwig Jeffrey Jerome
Chief Commercial Officer
$215.25K (8) scheduled
−$215.25K
156,792
0.3037%
$1.43M
Dorval Allison
Director
$194.65K (4) scheduled
−$194.65K
90,780
0.1759%
$828.19K
Stuglik Brian M
Director
$188.47K (5) scheduled
−$188.47K
113,858
0.2206%
$1.04M
CHARNAS ROBERT
See Remarks
$171.96K (3)
−$171.96K
26,453
0.0512%
$241.33K
+10,315%
Miller Ann Calby
Director
$147.16K (1)
−$147.16K
40,732
0.0789%
$371.60K
Wong Alvin F
Chief Scientific Officer
$88.52K (9) scheduled
−$88.52K
141,241
0.2736%
$1.29M
+672.5%
ZAVRL FRANK
Director
960,069
1.86%
$8.76M
+5.6%
O'Dowd Hugh
Director
25,748
0.0499%
$234.90K

Nothing of that kind in this period.

What was left out

Form 4 filings counted 366
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 63
Sales straight out of an exercise 5
Sales at will 224
Transactions with no price 0
Shares from compensation/vesting 6,460,640
Sales filed before the plan box existed 221
History held since 14 Oct 2016